Tomato Extract Powder 5% Lycopene

Solanum lycopersicum L. Fruit extract; Lycopene 5% by HPLC; result 5.12%, supported by representative batch LXFM210514.

Description

COA-BACKED BOTANICAL INGREDIENT

Solanum lycopersicum L. Fruit Extract

Tomato Extract Powder 5% Lycopene is presented for B2B ingredient qualification using representative batch evidence and batch-specific analytical language.

Tomato Extract Powder 5% Lycopene source image

COA-Backed Specification

Botanical identity Solanum lycopersicum L.
Plant part Fruit
Form and colour Fine red powder
Assay Lycopene 5% by HPLC; result 5.12%
Particle size 98% through 80 mesh
Loss on drying <=5.0%; result 3.54%
Ash <=5.0%; result 4.11%
Representative batch LXFM210514
Manufacture date 14 May 2021
Shelf life Two years when stored properly

Representative values do not replace the current shipment COA.

Tomato Extract Powder 5% Lycopene applications image

Buyer Decision Guide

Use Tomato Extract Powder 5% Lycopene when the brief requires Lycopene 5% by HPLC; result 5.12%. Compare the stated marker and analytical basis before accepting an alternative concentration.

  • Evaluation sample typically 10-20 g
  • Regular MOQ typically 1 kg
  • Typical lead time 7-15 working days
Tomato Extract Powder 5% Lycopene quality image

How This Grade Differs

Tomato Extract Powder 5% Lycopene is qualified using botanical identity: Solanum lycopersicum L.; plant part: Fruit; offered grade: Lycopene 5% by HPLC; result 5.12%. The defining purchasing attribute is Lycopene 5% by HPLC; result 5.12%; a ratio extract or untreated botanical powder does not establish the same marker specification.

When an alternative to Tomato Extract Powder 5% Lycopene is required, compare it against this page’s identity, grade and batch-document requirements.

Browse ingredients related to Tomato Extract Powder 5% Lycopene

For a Tomato Extract Powder 5% Lycopene substitution review, match botanical identity, plant part, grade-defining assay or ratio, analytical basis, physical form and offered-lot documentation.

Quality and Documentation

Representative batch LXFM210514 supports the specification table above. Use the cited record for preliminary comparison and request the offered-lot COA for final technical approval.

Frequently Asked Questions

What specification defines Tomato Extract Powder 5% Lycopene?

For Tomato Extract Powder 5% Lycopene: Lycopene 5% by HPLC; result 5.12%.

Which source and plant-part details matter?

For Tomato Extract Powder 5% Lycopene: Match Solanum lycopersicum L., Fruit across the quotation, specification and offered-batch COA. The differentiating target is Lycopene 5% by HPLC; result 5.12%; confirm the marker, unit and stated analytical basis.

What is the role of the representative COA?

For Tomato Extract Powder 5% Lycopene: The page cites representative batch LXFM210514. Final approval requires the current lot's identity, specification results and relevant dates.

What COA should accompany commercial approval?

For Tomato Extract Powder 5% Lycopene: Current batch documentation should be reviewed before purchase; a representative document is useful for screening but does not release a shipment.

How should analytical and physical limits be assessed?

For Tomato Extract Powder 5% Lycopene: Do not assess Lycopene 5% by HPLC; result 5.12% in isolation; particle size, moisture or drying data and market-relevant safety limits can also affect acceptance.

What determines MOQ and lead time for this grade?

For Tomato Extract Powder 5% Lycopene: Confirm MOQ and timing on the live quotation because stock position, testing, packing and destination requirements can change both.

Can packing or physical parameters be reviewed?

For Tomato Extract Powder 5% Lycopene: Alternative packing or selected parameters may be considered case by case, subject to production feasibility and a revised written specification.

Request COA, Sample or Quotation

Contact LongBio

Reviews

There are no reviews yet.

Be the first to review “Tomato Extract Powder 5% Lycopene”

Your email address will not be published. Required fields are marked *